Last reviewed · How we verify
NCT05482581
The Impact of Policies Regarding E-cigarette on Adolescents and Young Adults' Cognition and Behavior for E-cigarette
trial testing Questionnaires set in E-Cig Use in 453 participants. Status unknown.
1 January 2024
Quick facts
| Lead sponsor | Sun Yat-sen University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 453 |
| Start date | 27 May 2022 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 February 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Questionnaires set
Conditions studied
- E-Cig Use — all drugs for E-Cig Use →
Sponsor
Sun Yat-sen University
Who can join
Adults 14 to 35, any sex, with E-Cig Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Based on the Knowledge，Attitude，Belief and Practice model(KABP model), this study intends to use a mixed method to explore the influencing mechanism of youth and adolescents' cognition and behavior for e-cigarette before and after the promulgation of the new regulations on e-cigarette . Information from network epidemiology (including network links, text, images, audio, video, etc.) was captured to expand the data abundance, and the retrieval behavior of e-cigarettes and the trajectory changes of e-cigarette-related events were explored. Finally, summarize the data, integrate and explain the influencing mechanism of youth and adolescents' attention and cognition on e-cigarette, and provide ideas for subsequent e-cigarette control, as well as theoretical and practical basis for relevant departments to formulate corresponding policies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interventions to prevent or cease electronic cigarette use in children and adolescents.
Barnes C, Turon H, McCrabb S, Hodder RK, et al · · 2023 · cited 14× · PMID 37965949 · DOI 10.1002/14651858.cd015511.pub2
Verify or expand the search:
- PubMed search for NCT05482581
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaires set
Trials testing the same drug.
- NCT07515430 — The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphobl · enrolling by invitation
- NCT06303089 — Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients · completed
- NCT05891301 — Construction and Validation of Risk Prediction Model for Gastrointestinal Dysfunction of Patient With Colorectal Cancer · unknown
- NCT05493020 — The Association Between Watching Mukbang Videos and the Appetite of Children With Cancer · completed
- NCT05474651 — Influencing Factors and Trigger Mechanism of Relapse in Expectant Fathers Who Quit Smoking · active not recruiting
Other recruiting trials for E-Cig Use
Currently open trials in the same condition.
- NCT07039292 — Clinical Alternatives for Reducing Harm Using E-cigarettes · NA · recruiting
- NCT07167225 — Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study) · recruiting
- NCT06862050 — BREATHE Free: a Pilot Feasibility Trial · NA · recruiting
- NCT06860698 — The Impact of Chronic E-Cigarette Usage on Microvascular Health · recruiting
- NCT05869318 — Respiratory Effects of E-Cigarettes in Obese Youth · NA · active not recruiting
Other Sun Yat-sen University trials
Trials by the same sponsor.
- NCT07255612 — Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negat · Phase 2 · not yet recruiting
- NCT07371897 — Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial · Phase 3 · not yet recruiting
- NCT07489703 — SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC · Phase 2 · not yet recruiting
- NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
- NCT07522281 — Evaluation of an Undisturbed Embryo Culture System for Embryo Development in IVF/ICSI Cycles · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05482581 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sun Yat-sen University
- Last refreshed: 10 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05482581.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing